(NEW YORK)–Ludlow Research initiates research opinion on Ehave, Inc. (OTC: EHVVF), a leading healthcare services and technology company, based on growing risk for mental health crisis and demand for alternative treatment options.
BULLISH OUTLOOK IN RECESSION
Ehave is a healthcare technology company, which is focused on healthcare data collection, management, and analytics for the mental health and wellness market.
Their core mission is to create safe and effective therapeutics that will help achieve better patient outcomes when dealing with brain health issues such as depression, anxiety, and PTSD.
As economies across the globe emerge from pandemic restrictions many nations are facing a growing mental health crisis resulting from economic stress and long waiting lines for psychiatric care.
Increases in mental health disorders, such as anxiety, depression, and post-traumatic stress disorder (PTSD) are resulting in renewed demand for alternative mental health treatments, which could result in higher consumer demand for Ehave services into 2023.
This business model could position Ehave operations as sort of a hedge to any economic recession.
For these reasons, Ludlow Research has initiated coverage on Ehave, Inc. (OTC:EHVVF) with a ‘speculative’ valuation target of $0.04 per share, or $14 million market valuation.
To download report please visit https://ludlowresearch.com/reports/
HEALTHCARE DATA MANAGEMENT
MetaHealthU platform is a powerful mobile application that empowers individuals to take complete control of their health and their healthcare data. MetaHealthU allows users to securely track all their health data from wearables, Electronic Health Records Systems (EHRs), doctors, and medical labs.
Healthcare data management is the process of storing, protecting, and analyzing data pulled from diverse sources. Managing the wealth of available healthcare data allows health systems to create holistic views of patients, personalize treatments, improve communication, and enhance health outcomes.
BLOCKCHAIN IN HEALTHCARE
MetaHealthU is developing platfrom to utilize Web3 blockchain technology for healthcare data management and secure data storage.
Integrating Web3 in healthcare can give the power over data back to users and help handle a structured data management system. The data stored in Web3 is distributed, personalized and traceable, eventually bringing transparency, accessibility and affordability to the healthcare ecosystem.
To receive investor updates on this report register at
About Ehave, Inc.
Ehave is a leading healthcare services and technology company, focused on progressing psychedelics-to-Therapeutics by engineering novel compounds and new treatment protocols for treating brain health. Together with our network of scientists and mental health professionals, we are on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues, leveraging clinical data to help us achieve optimal patient outcomes. Ehave’s operations span across the entire USA, Canada, Jamaica, and Australia. Additional information on Ehave can be found on the Company’s website at: www.ehave.com